Increased Hypothalamic Expression of the p75 Tumor Necrosis Factor Receptor in New Zealand Obese Mice

Previous studies have demonstrated that tumor necrosis factor-α (TNF-α) production from adipose tissue is elevated in obese animal models and in obese humans. It plays an important role in the induction of insulin resistance in experimental animals. In this study, we examined hypothalamic tissue expression of TNF-α and its receptors and TNF-α expression of adipose tissue in lean C57BLKSJ^+/+ and obese polygenic New Zealand obese (NZO) mice. Obese animals exhibited hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and hypercholesterinemia. Using RT-PCR, we observed increased expression (2.4-fold) of TNF receptor 2 (p75) in the hypothalamus of obese mice. TNF-α expression in adipose tissue of obese mice was eight times higher than in controls. TNF-α and TNF receptor 1 (p55) expression in hypothalamic tissue was similar in obese and lean animals. These results suggest that the hypothalamic TNF receptor 2 (p75) might play a role in obesity by modulating the actions of TNF-α in conditions of leptin resistance.

Key words:

TNF-alpha - TNF Receptors - New Zealand Obese Mouse - Obesity - Hypothalamus

References

• 1 Old L J. Tumor necrosis factor (TNF).  Science. 1985;  230 630-632
• 2 Hofmann C, Lorenz K, Braithwaite S S, Colca J R, Palazuk B J, Hotamisligil G S, Spiegelman B M. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.  Endocrinology. 1994;  134 264-270
• 3 Norman R A, Bogardus C, Ravussin E. Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians.  J Clin Invest. 1995;  96 158-162
• 4 Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.  Science. 1993;  259 87-91
• 5 Hotamisligil G S, Budavari A, Murray D, Spiegelman B M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.  J Clin Invest. 1994;  94 1543-1549
• 6 Hotamisligil G S, Arner P, Caro J F, Atkinson R L, Spiegelman B M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.  J Clin Invest. 1995;  95 2409-2415
• 7 Kern P A, Saghizadeh M, Ong J M, Bosch R J, Deem R, Simsolo R B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.  J Clin Invest. 995;  95 2111-2119
• 8 Liu L S, Spelleken M, Rohrig K, Hauner H, Eckel J. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.  Diabetes. 1998;  47 515-522
• 9 Hotamisligil G S, Murray D L, Choy L N, Spiegelman B M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor.  Proc Natl Acad Sci USA. 1994;  91 4854-4858
• 10 Begum N, Ragolia L. Effect of tumor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells.  Endocrinology. 1996;  137 2441-2446
• 11 Lang C H, Dobrescu C, Bagby G J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.  Endocrinology. 1992;  130 43-52
• 12 Zhang S, Kim K H. TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1).  FEBS Lett. 1995;  377 237-239
• 13 Vara E, Arias-Diaz J, Garcia C, Balibrea J L. Effect of cytokines on insulin release and glucose oxidation by cultured human islets of ventral and dorsal origin.  Transplant Proc. 1994;  26 695-697
• 14 Loetscher H, Steinmetz M, Lesslauer W. Tumor necrosis factor: receptors and inhibitors.  Cancer Cells. 1991;  3 221-226
• 15 Smith R A, Baglioni C. Characterization of TNF receptors.  Immunol Ser. 1992;  56 131-147
• 16 Tartaglia L A, Goeddel D V. Two TNF receptors.  Immunol Today. 1992;  13 151-153
• 17 Smith C A, Farrah T, Goodwin R G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.  Cell. 1994;  76 959-962
• 18 LeBoeuf R C, Schreyer S A. The role of tumor necrosis factor-α receptors in athrosclerosis.  Trends Cardiovas Med. 1998;  8 131-138
• 19 Pfeffer K, Matsuyama T, Kundig T M, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi P S, Kronke M, Mak T W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.  Cell. 1993;  73 457-467
• 20 Erickson S L, de Sauvage F J, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan K C, Schreiber R D, Goeddel D V, Moore M W. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.  Nature. 1994;  372 560-563
• 21 Merrill J E, Koyanagi Y, Zack J, Thomas L, Martin F, Chen I S. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.  J Virol. 1992;  66 2217-2225
• 22 Teuscher C, Hickey W F, Korngold R. An analysis of the role of tumor necrosis factor in the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic encephalomyelitis.  Clin Immunol Immunopathol. 1990;  54 442-453
• 23 Banks W A, Kastin A J, Broadwell R D. Passage of cytokines across the blood-brain barrier.  Neuroimmunomodulation. 1995;  2 241-248
• 24 Gutierrez E G, Banks W A, Kastin A J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.  J Neuroimmunol. 1993;  47 169-176
• 25 Herberg L, Coleman D L. Laboratory animals exhibiting obesity and diabetes syndromes.  Metabolism. 1977;  26 59-99
• 26 Igel M, Becker W, Herberg L, Joost H G. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse.  Endocrinology. 1997;  138 4234-4239
• 27 Rizk N M, Liu L S, Eckel J. Hypothalamic expression of neuropeptide-Y in the New Zealand obese mouse.  Int J Obes Relat Metab Disord. 1998;  22 1172-1177
• 28 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.  Anal Biochem. 1987;  162 156-169
• 29 Halaas J L, Boozer C, Blair-West J, Fidahusein N, Denton D A, Friedman J M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.  Proc Natl Acad Sci USA. 1997;  94 8878-8883
• 30 Hotamisligil G S, Arner P, Atkinson R L, Spiegelman B M. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.  Diabetes. 1997;  46 451-455
• 31 Breder C D, Hazuka C, Ghayur T, Klug C, Huginin M, Yasuda K, Teng M, Saper C B. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration.  Proc Natl Acad Sci USA. 1994;  91 11 393-11 397
• 32 Plata-Salaman C R, Vasselli J R, Sonti G. Differential responsiveness of obese (fa/fa) and lean (Fa/Fa) Zucker rats to cytokine-induced anorexia.  Obes Res. 1997;  5 36-42
• 33 Plata-Salaman C R, Oomura Y, Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system.  Brain Res. 1988;  448 106-114
• 34 Rizk N, Stammsen D, Preibisch G, Eckel J. Leptin and tumor necrosis factor-α induce the tyrosine phosphorylation of STAT proteins in the hypothalamus of normal rats in vivo.  Endocrinology. 2001;  142 3027-3032